Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.015 | 0.8664 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.015 | 0.8664 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0104 | 0.523 | 0.5391 |
Leishmania major | monoglyceride lipase, putative | 0.015 | 0.8664 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0104 | 0.523 | 0.5391 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0104 | 0.523 | 0.3545 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0104 | 0.523 | 0.0288 |
Chlamydia trachomatis | glucose-6-phosphate 1-dehydrogenase | 0.0103 | 0.5128 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.015 | 0.8664 | 1 |
Plasmodium vivax | PST-A protein | 0.015 | 0.8664 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.015 | 0.8664 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0104 | 0.523 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.261 | 0.3302 |
Plasmodium falciparum | esterase, putative | 0.015 | 0.8664 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.261 | 0.3302 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0104 | 0.523 | 0.3545 |
Treponema pallidum | glucose-6-phosphate 1-dehydrogenase | 0.0103 | 0.5128 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0132 | 0.7329 | 0.6385 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.015 | 0.8664 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0132 | 0.7329 | 0.6385 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.8664 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0104 | 0.523 | 0.5391 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0104 | 0.523 | 0.5391 |
Trichomonas vaginalis | conserved hypothetical protein | 0.015 | 0.8664 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.015 | 0.8664 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0104 | 0.523 | 0.5391 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0104 | 0.523 | 0.5391 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0112 | 0.5827 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0104 | 0.523 | 1 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0112 | 0.5827 | 0.6192 |
Loa Loa (eye worm) | glucose-6-phosphate dehydrogenase | 0.0103 | 0.5128 | 0.3407 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.261 | 0.3302 |
Plasmodium falciparum | lysophospholipase, putative | 0.015 | 0.8664 | 1 |
Echinococcus multilocularis | glucose 6 phosphate 1 dehydrogenase | 0.0103 | 0.5128 | 0.9611 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.8664 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0104 | 0.523 | 0.0288 |
Trichomonas vaginalis | 6-phosphogluconolactonase, putative | 0.0112 | 0.5827 | 0.6192 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0112 | 0.5827 | 0.6192 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.261 | 0.3302 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.015 | 0.8664 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.015 | 0.8664 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.015 | 0.8664 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.8664 | 1 |
Plasmodium falciparum | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0.0112 | 0.5827 | 0.1977 |
Trypanosoma brucei | polo-like protein kinase | 0.0104 | 0.523 | 0.0288 |
Giardia lamblia | Glucose-6-phosphate 1-dehydrogenase | 0.0112 | 0.5827 | 1 |
Mycobacterium ulcerans | lysophospholipase | 0.015 | 0.8664 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0132 | 0.7329 | 0.6385 |
Echinococcus granulosus | glucose 6 phosphate 1 dehydrogenase | 0.0103 | 0.5128 | 0.9611 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0104 | 0.523 | 0.0288 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0104 | 0.523 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.015 | 0.8664 | 1 |
Brugia malayi | glucose-6-phosphate dehydrogenase | 0.0103 | 0.5128 | 0.3407 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.8664 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.8664 | 1 |
Schistosoma mansoni | glucose-6-phosphate 1-dehydrogenase | 0.0103 | 0.5128 | 0.974 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0104 | 0.523 | 0.5391 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.0103 | 0.5128 | 0.4351 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.015 | 0.8664 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.261 | 0.3302 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.015 | 0.8664 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.39 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 by two fold broth dilution method | ChEMBL. | 24140916 |
MIC (functional) | = 1.56 ug ml-1 | Antifungal activity against Candida albicans after 48 hrs by two fold agar dilution method | ChEMBL. | 24140916 |
MIC (functional) | = 2.6 ug ml-1 | Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtitre assay | ChEMBL. | 24140916 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.